Antioxidant defence mechanisms: new players in the pathogenesis of non-alcoholic steatohepatitis?

被引:24
|
作者
Leclercq, IA [1 ]
机构
[1] Catholic Univ Louvain, Gastroenterol Unit, Belgian Natl Fonds Sci Res, B-1200 Brussels, Belgium
关键词
antioxidant pathway; glutathione; non-alcoholic fatty liver disease; oxidative stress;
D O I
10.1042/CS20030368
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This comment discusses the study by Videla and colleagues in this issue of Clinical Science in which they have analysed surgical liver biopsies from obese patients with non-alcoholic fatty liver disease and demonstrate that fatty liver is associated with a state of oxidative stress and a decreased antioxidant activity. As the disease progresses to steatohepatitis, the defect in antioxidant systems increases. Thus efficiency of antioxidant defence mechanisms, by setting the threshold at which pro-oxidants would become injurious, might represent a determining factor for disease progression from stable steatosis to steatohepatitis.
引用
收藏
页码:235 / 237
页数:3
相关论文
共 50 条
  • [41] New therapeutic perspectives in non-alcoholic steatohepatitis
    Ampuero, Javier
    Sanchez-Torrijos, Yolanda
    Aguilera, Virginia
    Bellido, Francisco
    Romero-Gomez, Manuel
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2018, 41 (02): : 128 - 142
  • [42] Non-alcoholic Steatohepatitis (NASH) and alcoholic Steatohepatitis (ASH)
    Roeb, Elke
    DRUG RESEARCH, 2021, 71 : S16 - S18
  • [43] Treatment of alcoholic and non-alcoholic steatohepatitis
    Stremmel, W
    Blechacz, B
    Herrmann, T
    Rost, D
    Mueller, S
    INTERNIST, 2001, 42 (12): : 1641 - +
  • [44] Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
    Lirussi, F.
    Azzalini, L.
    Orando, S.
    Orlando, R.
    Angelico, F.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [45] Combined alcoholic and non-alcoholic steatohepatitis
    Wandji, Line Carolle Ntandja
    Gnemmi, Viviane
    Mathurin, Philippe
    Louvet, Alexandre
    JHEP REPORTS, 2020, 2 (03)
  • [46] Pathophysiological mechanisms and therapeutic potentials of macrophages in non-alcoholic steatohepatitis
    Wu, Ruonan
    Nakatsu, Geicho
    Zhang, Xiang
    Yu, Jun
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (05) : 615 - 626
  • [47] Molecular mechanisms of fibrosis progression in non-alcoholic steatohepatitis (NASH)
    Hellerbrand, C.
    LIVER CIRRHOSIS: FROM PATHOPHYSIOLOGY TO DISEASE MANAGEMENT, 2008, 162 : 75 - +
  • [48] Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies
    CHEN Hao
    ZHOU Yang
    HAO Haiping
    XIONG Jing
    Chinese Journal of Natural Medicines, 2024, 22 (08) : 724 - 745
  • [49] Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies
    Chen, Hao
    Zhou, Yang
    Hao, Haiping
    Xiong, Jing
    CHINESE JOURNAL OF NATURAL MEDICINES, 2024, 22 (08) : 724 - 745
  • [50] Drugs and non-alcoholic steatohepatitis
    Farrell, GC
    STEATOHEPATITIS (NASH AND ASH), 2001, 121 : 132 - 139